B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter
Recall from a federal regulator
Headline as published by U.S. Food and Drug Administration (MedWatch) on Sep 3, 2026; collected by the wire Oct 1, 2026, 7:45 PM ET.
FOR IMMEDIATE RELEASE – September 3, 2026– Bethlehem, PA, B. Braun Medical Inc (B. Braun) is voluntarily recalling three (3) lots of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container, to the hospital/healthcare facility/user level due to presence of particulate matter identified
Coverage
Topics
- Recalls and safety alertsMatched on
Recall
Explore the named firms, organizations and MDL dockets above. Sources and method